Harrow, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 28.24 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.06B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE, as well as BYQLOVI; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for p...